159 related articles for article (PubMed ID: 7251830)
1. Antibiotic resistance in Providencia stuartii isolated in hospitals.
McHale PJ; Keane CT; Dougan G
J Clin Microbiol; 1981 Jun; 13(6):1099-104. PubMed ID: 7251830
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
Kocka FE; Srinivasan S; Mowjood M; Kantor HS
J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
[TBL] [Abstract][Full Text] [Related]
3. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
Hawkey PM
J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
[No Abstract] [Full Text] [Related]
4. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
Hollick GE; Nolte FS; Calnan BJ; Penner JL; Barton LJ; Spellacy A
Eur J Clin Microbiol; 1984 Dec; 3(6):521-5. PubMed ID: 6526019
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiological studies of increasing appearances of Proteus inconstans (Providencia stuartii) infections (author's transl)].
Kopf PO; Freitag V; Caselitz FH; Kolbe S
Immun Infekt; 1980; 8(3):96-100. PubMed ID: 7461700
[TBL] [Abstract][Full Text] [Related]
6. Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area.
Giakkoupi P; Tryfinopoulou K; Polemis M; Pappa O; Miriagou V; Vatopoulos A
Diagn Microbiol Infect Dis; 2015 May; 82(1):62-4. PubMed ID: 25752202
[TBL] [Abstract][Full Text] [Related]
7. O serotyping of Providencia stuartii isolates collected from twelve hospitals.
Penner JL; Hinton NA; Duncan IB; Hennessy JN; Whiteley GR
J Clin Microbiol; 1979 Jan; 9(1):11-4. PubMed ID: 429535
[TBL] [Abstract][Full Text] [Related]
8. Emergence of resistance of Providencia stuartii to multiple antibiotics: speciation and biochemical characterization of Providencia.
Overturf GD; Wilkins J; Ressler R
J Infect Dis; 1974 Mar; 129(3):353-7. PubMed ID: 4493148
[No Abstract] [Full Text] [Related]
9. Speciation, serotyping, antimicrobial sensitivity and plasmid content of Proteeae from the environment of calf-rearing units in South West England.
Hawkey PM; Penner JL; Linton AH; Hawkey CA; Crisp LJ; Hinton M
J Hyg (Lond); 1986 Dec; 97(3):405-17. PubMed ID: 3540110
[TBL] [Abstract][Full Text] [Related]
10. Differences among Providencia species in their in vitro susceptibilities to five antibiotics.
Penner JL; Preston MA
Antimicrob Agents Chemother; 1980 Dec; 18(6):868-71. PubMed ID: 7235674
[TBL] [Abstract][Full Text] [Related]
11. Letter: Providencia stuartii infections.
Keane CT; English LF; Wise R
Lancet; 1975 Nov; 2(7943):1045. PubMed ID: 53535
[No Abstract] [Full Text] [Related]
12. [Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1991 Feb; 44(2):140-9. PubMed ID: 2041155
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial dissemination of Providencia stuartii isolates carrying bla OXA-48, bla PER-1, bla CMY-4 and qnrA6 in a Tunisian hospital.
Mnif B; Ktari S; Chaari A; Medhioub F; Rhimi F; Bouaziz M; Hammami A
J Antimicrob Chemother; 2013 Feb; 68(2):329-32. PubMed ID: 23014719
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
Ducan IB; Penner JL
Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
[TBL] [Abstract][Full Text] [Related]
15. Inducible expression of an aminoglycoside-acetylating enzyme in Providencia stuartii.
Swiatlo E; Kocka FE
J Antimicrob Chemother; 1987 Jan; 19(1):27-30. PubMed ID: 3549668
[TBL] [Abstract][Full Text] [Related]
16. Providencia rustigianii: a new species in the family Enterobacteriaceae formerly known as Providencia alcalifaciens biogroup 3.
Hickman-Brenner FW; Farmer JJ; Steigerwalt AG; Brenner DJ
J Clin Microbiol; 1983 Jun; 17(6):1057-60. PubMed ID: 6874899
[TBL] [Abstract][Full Text] [Related]
17. Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Oikonomou O; Liakopoulos A; Phee LM; Betts J; Mevius D; Wareham DW
Microb Drug Resist; 2016 Jul; 22(5):379-86. PubMed ID: 27380549
[TBL] [Abstract][Full Text] [Related]
18. Incidence of antibiogram, antibiotic resistance genes and class 1 and 2 integrons in tribe Proteeae with IMP27 gene for the first time in Providencia sp. isolated from pet turtles.
Pathirana HNKS; Shin GW; Wimalasena SHMP; Hossain S; De Silva BCJ; Dahanayake PS; Heo GJ
Lett Appl Microbiol; 2018 Dec; 67(6):620-627. PubMed ID: 30238643
[TBL] [Abstract][Full Text] [Related]
19. Evolution of an R plasmid from a cryptic plasmid by transposition of two copies of Tn1 in Providencia stuartii.
Hawkey PM; Bennett PM; Hawkey CA
J Gen Microbiol; 1985 Apr; 131(4):927-33. PubMed ID: 2985741
[TBL] [Abstract][Full Text] [Related]
20. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.
O'Hara CM; Brenner FW; Miller JM
Clin Microbiol Rev; 2000 Oct; 13(4):534-46. PubMed ID: 11023955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
